TBHC deal: Bed Bath & Beyond (NYSE: BBBY) details merger and debt
Bed Bath & Beyond, Inc. filed an amended current report to add detailed financial statements for The Brand House Collective (TBHC) and pro forma information for their completed merger. The amendment includes TBHC’s audited results for the three years ended January 31, 2026 and combined unaudited pro forma financials for the year ended December 31, 2025.
TBHC generated net sales of about $395.8 million in fiscal 2025 but reported a net loss of roughly $45.9 million and a shareholders’ deficit of about $53.9 million as of January 31, 2026. The notes describe significant related-party funding and revenue-sharing arrangements with Bed Bath & Beyond, including term loans and a collaboration agreement accounted for as debt, as well as a pending merger under which TBHC will become a wholly owned subsidiary.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Collaboration Agreement financial
self-insurance reserves financial
shareholders’ deficit financial
Going concern assessment financial
effective interest method financial
incremental borrowing rate financial
|
|
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
|
|
|
|
| Item 9.01. |
Financial Statements and Exhibits.
|
|
Exhibit Number
|
Exhibit Description
|
|
23.1
|
Consent of Ernst & Young LLP, independent auditors of TBHC.
|
|
99.1
|
Audited consolidated balance sheets of TBHC and its subsidiaries as of January 31, 2026 and February 1, 2025, the related consolidated statements of operations, shareholders’
(deficit) equity, and cash flows for each of the years in the three-year period ended January 31, 2026, and the related notes thereto.
|
|
99.2
|
Unaudited pro forma condensed combined balance sheet of the Company as of December 31, 2025, the unaudited pro forma condensed combined statement of
operations of the Company for the year ended December 31, 2025, and the related notes thereto.
|
|
104
|
The cover page from this Current Report on Form 8-K, formatted in Inline XBRL (included as Exhibit 101).
|
|
BED BATH & BEYOND, INC.
|
||
|
By:
|
/s/ Brian LaRose
|
|
|
Brian LaRose
|
||
|
Chief Financial Officer
|
|
Date: May 8, 2026
|
|
|
|
Report of Ernst & Young LLP, Independent Registered Public Accounting Firm (PCAOB ID: 42)
|
2
|
|
Consolidated Balance Sheets as of January 31, 2026 and February 1, 2025
|
5
|
|
Consolidated Statements of Operations for the 52 Weeks Ended January 31, 2026 and February 1, 2025 and the 53 Weeks Ended February 3, 2024
|
6
|
|
Consolidated Statements of Shareholders’ (Deficit) Equity for the 52 Weeks Ended January 31, 2026 and February 1, 2025 and the 53 Weeks Ended February 3, 2024
|
7
|
|
Consolidated Statements of Cash Flows for the 52 Weeks Ended January 31, 2026 and February 1, 2025 and the 53 Weeks Ended February 3, 2024
|
8
|
|
Notes to Consolidated Financial Statements
|
9
|
![]() |
Ernst & Young LLP
222 2nd Avenue South
Suite 2100
Nashville, TN 37201
|
Tel: +1 615 252-2000
ey.com
|
Report of Independent Registered Public Accounting Firm
![]() |
|
Estimate of Self-Insurance Reserves
|
||
|
Description of
the Matter
|
At January 31, 2026, the Company’s reserves for self-insurance risks was $3.7 million, net of estimated stop-loss insurance receivables. As
discussed in Note 1 of the consolidated financial statements, the Company retains a significant portion of risk for loss exposure for claims. Accordingly, provisions are recorded based upon periodic estimates of such losses, as determined
by management. The future cost for the claims exposure is estimated using actuarial methods that consider assumptions for a number of factors including, but not limited to, historical claims experience and loss development factors.
Auditing management’s estimate of certain self-insurance reserves was complex and judgmental due to the significant assumptions and
judgments required by management to project the exposure for incurred claims that remain unresolved, including those which have been incurred but not yet reported to the Company.
|
|
|
How We Addressed the Matter in Our Audit
|
To test the Company’s estimate of certain self-insurance reserves, we performed audit procedures that included, among others, assessing the actuarial valuation methodologies
utilized by management, testing the significant assumptions described above, testing the related underlying data used by the Company in its evaluation for completeness and accuracy, and testing the mathematical accuracy of the
calculations. Our audit procedures also included, among others, comparing the significant assumptions used by management to industry accepted actuarial assumptions and reassessing the accuracy of management’s historical estimates utilized
in prior period evaluations. We involved our actuarial valuation specialists to assist in assessing the valuation methodologies and significant assumptions noted above and to develop an independent range of estimates for certain
self-insurance reserves which we then compared to management’s estimates.
|
![]() |
|
Estimate of Collaboration Agreement Fees Debt
|
||
|
Description of the Matter
|
As described in Note 1 and 5 to the consolidated financial statements, the sale of a percentage of the Company’s future revenue to Bed Bath
& Beyond, Inc. under the Collaboration Agreement (modified in May 2025), have been accounted for as debt financing and the Company has recorded a liability of $6.6 million as of January 31, 2026, which is included in current related
party debt and related party debt, net on the consolidated balance sheet. The liability will be accreted to the total of the payments as interest expense using the effective interest method over the life of the Collaboration Agreement.
The Company will periodically assess the estimated payments to Bed Bath & Beyond, Inc. and to the extent the amount or timing of such fees is materially different than the original estimates, an adjustment will be recorded
prospectively to increase or decrease interest expense.
Auditing the Collaboration Agreement fees debt was judgmental due to the estimation uncertainty in determining the future revenue included
in the effective interest rate model, which is affected by future market conditions.
|
|
|
How We Addressed the Matter in Our Audit
|
To test the Company’s modified Collaboration Agreement fees debt, our audit procedures included, among others, assessing the projections of future revenue. We compared the
future revenue to historical revenue and current industry, market and economic trends. We recalculated interest expense based on the amortization schedules and estimates of cash payments using the effective interest method and performed
sensitivity analyses to evaluate the changes in the Collaboration Agreement fees debt, and associated interest expense, that would result from changes in future revenue.
|
|
January 31, 2026
|
February 1, 2025
|
|||||||
|
(In thousands, except share data)
|
||||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
2,932
|
$
|
3,820
|
||||
|
Inventories, net
|
58,758
|
81,899
|
||||||
|
Prepaid expenses and other current assets
|
7,049
|
5,585
|
||||||
|
Total current assets
|
68,739
|
91,304
|
||||||
|
Property and equipment:
|
||||||||
|
Equipment
|
18,017
|
18,905
|
||||||
|
Furniture and fixtures
|
53,749
|
61,354
|
||||||
|
Leasehold improvements
|
85,825
|
97,635
|
||||||
|
Computer software and hardware
|
77,784
|
78,847
|
||||||
|
Projects in progress
|
343
|
287
|
||||||
|
Property and equipment, gross
|
235,718
|
257,028
|
||||||
|
Accumulated depreciation
|
(221,008
|
)
|
(234,966
|
)
|
||||
|
Property and equipment, net
|
14,710
|
22,062
|
||||||
|
Operating lease right-of-use assets
|
102,280
|
121,229
|
||||||
|
Other assets
|
2,604
|
7,593
|
||||||
|
Total assets
|
$
|
188,333
|
$
|
242,188
|
||||
|
LIABILITIES AND SHAREHOLDERS’ DEFICIT
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
55,348
|
$
|
43,935
|
||||
|
Accrued expenses and other liabilities
|
17,893
|
20,183
|
||||||
|
Operating lease liabilities
|
33,821
|
39,355
|
||||||
|
Current debt, net
|
—
|
49,199
|
||||||
|
Current related party debt
|
1,361
|
—
|
||||||
|
Total current liabilities
|
108,423
|
152,672
|
||||||
|
Operating lease liabilities
|
78,185
|
95,085
|
||||||
|
Long-term debt, net
|
15,986
|
10,003
|
||||||
|
Related party debt, net
|
36,444
|
—
|
||||||
|
Other liabilities
|
3,172
|
3,445
|
||||||
|
Total liabilities
|
242,210
|
261,205
|
||||||
|
Commitments and contingencies (Note 10)
|
—
|
—
|
||||||
|
Shareholders’ (deficit) equity:
|
||||||||
|
Preferred stock, no par value, 10,000,000 shares authorized; no shares issued or outstanding at January 31, 2026, and
February 1, 2025
|
—
|
—
|
||||||
|
Common stock, no par value, 80,000,000 and 100,000,000 shares authorized; 22,461,383 and 13,117,942 shares issued and
outstanding at January 31, 2026, and February 1, 2025, respectively
|
188,549
|
177,543
|
||||||
|
Accumulated deficit
|
(242,426
|
)
|
(196,560
|
)
|
||||
|
Total shareholders’ deficit
|
(53,877
|
)
|
(19,017
|
)
|
||||
|
Total liabilities and shareholders’ deficit
|
$
|
188,333
|
$
|
242,188
|
||||
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1, 2025
|
53 Weeks
Ended
February 3, 2024
|
||||||||||
|
(In thousands, except per share data)
|
||||||||||||
|
Net sales
|
$
|
395,782
|
$
|
441,360
|
$
|
468,690
|
||||||
|
Cost of sales
|
310,709
|
319,354
|
341,700
|
|||||||||
|
Gross profit
|
85,073
|
122,006
|
126,990
|
|||||||||
|
Operating expenses:
|
||||||||||||
|
Compensation and benefits
|
76,816
|
77,722
|
82,152
|
|||||||||
|
Other operating expenses
|
53,639
|
54,699
|
62,863
|
|||||||||
|
Depreciation (exclusive of depreciation included in cost of sales)
|
2,319
|
3,509
|
4,522
|
|||||||||
|
Gain on sale of internally developed intangible assets
|
(10,000
|
)
|
—
|
—
|
||||||||
|
Asset impairment
|
2,013
|
109
|
1,867
|
|||||||||
|
Total operating expenses
|
124,787
|
136,039
|
151,404
|
|||||||||
|
Operating loss
|
(39,714
|
)
|
(14,033
|
)
|
(24,414
|
)
|
||||||
|
Interest expense
|
6,024
|
5,949
|
3,317
|
|||||||||
|
Loss on extinguishment of debt
|
—
|
3,338
|
—
|
|||||||||
|
Other income
|
(230
|
)
|
(504
|
)
|
(499
|
)
|
||||||
|
Loss before income taxes
|
(45,508
|
)
|
(22,816
|
)
|
(27,232
|
)
|
||||||
|
Income tax expense
|
358
|
316
|
519
|
|||||||||
|
Net loss
|
$
|
(45,866
|
)
|
$
|
(23,132
|
)
|
$
|
(27,751
|
)
|
|||
|
Loss per share:
|
||||||||||||
|
Basic
|
$
|
(2.05
|
)
|
$
|
(1.77
|
)
|
$
|
(2.16
|
)
|
|||
|
Diluted
|
$
|
(2.05
|
)
|
$
|
(1.77
|
)
|
$
|
(2.16
|
)
|
|||
|
Weighted average shares outstanding:
|
||||||||||||
|
Basic
|
22,369
|
13,068
|
12,871
|
|||||||||
|
Diluted
|
22,369
|
13,068
|
12,871
|
|||||||||
|
Common Stock
|
Accumulated
Deficit
|
Total
Shareholders’
(Deficit)
Equity
|
||||||||||||||
|
Shares
|
Amount
|
|||||||||||||||
|
(In thousands, except share data)
|
||||||||||||||||
|
Balance at January 28, 2023
|
12,754,368
|
$
|
175,450
|
$
|
(145,677
|
)
|
$
|
29,773
|
||||||||
|
Restricted stock issued
|
202,967
|
—
|
—
|
—
|
||||||||||||
|
Net share settlement of restricted stock units
|
(31,313
|
)
|
(84
|
)
|
—
|
(84
|
)
|
|||||||||
|
Stock-based compensation expense
|
—
|
1,186
|
—
|
1,186
|
||||||||||||
|
Net loss
|
—
|
—
|
(27,751
|
)
|
(27,751
|
)
|
||||||||||
|
Balance at February 3, 2024
|
12,926,022
|
176,552
|
(173,428
|
)
|
3,124
|
|||||||||||
|
Restricted stock issued
|
215,591
|
—
|
—
|
—
|
||||||||||||
|
Net share settlement of restricted stock units
|
(23,671
|
)
|
(51
|
)
|
—
|
(51
|
)
|
|||||||||
|
Stock-based compensation expense
|
—
|
1,042
|
—
|
1,042
|
||||||||||||
|
Net loss
|
—
|
—
|
(23,132
|
)
|
(23,132
|
)
|
||||||||||
|
Balance at February 1, 2025
|
13,117,942
|
177,543
|
(196,560
|
)
|
(19,017
|
)
|
||||||||||
|
Restricted stock issued
|
141,006
|
—
|
—
|
—
|
||||||||||||
|
Net share settlement of restricted stock units
|
(42,165
|
)
|
(55
|
)
|
—
|
(55
|
)
|
|||||||||
|
Issuance of common stock to Bed Bath & Beyond, Inc. for subscription agreement
|
4,324,324
|
7,730
|
—
|
7,730
|
||||||||||||
|
Issuance of common stock to convert term loan and accrued interest
|
4,610,141
|
6,705
|
—
|
6,705
|
||||||||||||
|
Issuance of common stock to Consensus Securities LLC for subscription agreement
|
310,135
|
—
|
—
|
—
|
||||||||||||
|
Stock-based compensation expense
|
—
|
645
|
—
|
645
|
||||||||||||
|
Loss on debt extinguishment from a related party
|
—
|
(4,019
|
)
|
—
|
(4,019
|
)
|
||||||||||
|
Net loss
|
—
|
—
|
(45,866
|
)
|
(45,866
|
)
|
||||||||||
|
Balance at January 31, 2026
|
22,461,383
|
$
|
188,549
|
$
|
(242,426
|
)
|
$
|
(53,877
|
)
|
|||||||
|
52 Weeks Ended
January 31, 2026
|
52 Weeks Ended
February 1, 2025
|
53 Weeks Ended
February 3, 2024
|
||||||||||
|
(In thousands)
|
||||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net loss
|
$
|
(45,866
|
)
|
$
|
(23,132
|
)
|
$
|
(27,751
|
)
|
|||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||||||
|
Depreciation of property and equipment
|
8,242
|
9,745
|
11,980
|
|||||||||
|
Amortization of debt issuance costs and original issue discount costs
|
1,873
|
898
|
124
|
|||||||||
|
Asset impairment
|
2,013
|
109
|
1,867
|
|||||||||
|
Loss on disposal of property and equipment
|
290
|
17
|
9
|
|||||||||
|
Stock-based compensation expense
|
645
|
1,042
|
1,186
|
|||||||||
|
Loss on extinguishment of debt
|
—
|
3,338
|
—
|
|||||||||
|
Gain on disposal of internally developed intangible assets
|
(10,000
|
)
|
—
|
—
|
||||||||
|
Changes in assets and liabilities:
|
||||||||||||
|
Inventories, net
|
23,141
|
(7,809
|
)
|
9,981
|
||||||||
|
Prepaid expenses and other current assets
|
(1,464
|
)
|
2,018
|
(2,525
|
)
|
|||||||
|
Accounts payable
|
11,595
|
(1,886
|
)
|
2,186
|
||||||||
|
Accrued expenses and other liabilities
|
(3,080
|
)
|
(2,500
|
)
|
(3,146
|
)
|
||||||
|
Operating lease assets and liabilities
|
(3,759
|
)
|
100
|
(8,585
|
)
|
|||||||
|
Other assets and liabilities
|
4,469
|
(1,191
|
)
|
198
|
||||||||
|
Net cash used in operating activities
|
(11,901
|
)
|
(19,251
|
)
|
(14,476
|
)
|
||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Proceeds from sale of property and equipment
|
(111
|
)
|
38
|
148
|
||||||||
|
Proceeds from sale of internally developed intangible assets
|
10,000
|
—
|
—
|
|||||||||
|
Capital expenditures
|
(2,814
|
)
|
(2,390
|
)
|
(4,779
|
)
|
||||||
|
Net cash provided by (used in) investing activities
|
7,075
|
(2,352
|
)
|
(4,631
|
)
|
|||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Borrowings on revolving line of credit
|
343,162
|
45,100
|
64,000
|
|||||||||
|
Repayments on revolving line of credit
|
(370,176
|
)
|
(36,100
|
)
|
(45,000
|
)
|
||||||
|
Borrowings on FILO term loan
|
—
|
10,000
|
—
|
|||||||||
|
Repayments on FILO term loan
|
—
|
(10,000
|
)
|
—
|
||||||||
|
Payment of prepayment penalties on extinguishment of debt
|
—
|
(2,638
|
)
|
—
|
||||||||
|
Proceeds from Bed Bath & Beyond, Inc. term loan transactions
|
24,436
|
17,000
|
—
|
|||||||||
|
Payments of debt and equity issuance costs
|
(1,429
|
)
|
(1,693
|
)
|
(1,175
|
)
|
||||||
|
Cash used in net share settlement of stock options and restricted stock units
|
(55
|
)
|
(51
|
)
|
(84
|
)
|
||||||
|
Proceeds from issuance of common stock
|
8,000
|
—
|
—
|
|||||||||
|
Net cash provided by financing activities
|
3,938
|
21,618
|
17,741
|
|||||||||
|
Cash and cash equivalents:
|
||||||||||||
|
Net (decrease) increase
|
(888
|
)
|
15
|
(1,366
|
)
|
|||||||
|
Beginning of the year
|
3,820
|
3,805
|
5,171
|
|||||||||
|
End of the year
|
$
|
2,932
|
$
|
3,820
|
$
|
3,805
|
||||||
|
Supplemental cash flow information:
|
||||||||||||
|
Interest paid
|
$
|
4,076
|
$
|
4,795
|
$
|
3,290
|
||||||
|
Income taxes paid
|
350
|
335
|
561
|
|||||||||
|
Supplemental schedule of non-cash activities:
|
||||||||||||
|
Non-cash accruals for purchases of property and equipment
|
$
|
363
|
$
|
369
|
$
|
504
|
||||||
|
Non-cash accruals for debt issuance costs
|
673
|
534
|
1,180
|
|||||||||
|
Increase in operating lease liabilities from new or modified leases
|
9,399
|
29,289
|
28,563
|
|||||||||
|
Conversion of convertible note, accrued interest and unamortized debt issuance costs into common stock
|
6,705
|
—
|
—
|
|||||||||
|
Common stock issued in exchange for debt issuance costs
|
574
|
—
|
—
|
|||||||||
|
January 31,
2026
|
February 1,
2025
|
February 3,
2024
|
||||||||||
|
Gift card liability, net of estimated breakage (included in accrued expenses and other liabilities)
|
$
|
9,363
|
$
|
10,673
|
$
|
12,008
|
||||||
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||
|
Gift card breakage revenue (included in net sales)
|
$
|
949
|
$
|
1,120
|
$
|
2,195
|
||||||
|
Gift card redemptions recognized in the current period related to amounts included in the gift card contract liability
balance as of the prior period
|
3,234
|
3,962
|
4,800
|
|||||||||
|
January 31,
2026
|
February 1,
2025
|
|||||||
|
Gift cards
|
$
|
9,363
|
$
|
10,673
|
||||
|
Salaries and wages
|
1,949
|
1,616
|
||||||
|
Workers’ compensation and general liability reserves
|
1,803
|
1,981
|
||||||
|
Loyalty program deferred revenue
|
1,159
|
1,493
|
||||||
|
Sales taxes
|
1,068
|
1,131
|
||||||
|
Sales returns reserve
|
699
|
1,046
|
||||||
|
Deferred e-commerce revenue
|
309
|
607
|
||||||
|
Employee medical insurance reserves
|
272
|
392
|
||||||
|
Other
|
1,271
|
1,244
|
||||||
|
$
|
17,893
|
$
|
20,183
|
|||||
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||
|
Current tax expense:
|
||||||||||||
|
Federal
|
$
|
—
|
$
|
—
|
$
|
46
|
||||||
|
State
|
358
|
316
|
473
|
|||||||||
|
Income tax expense
|
$
|
358
|
$
|
316
|
$
|
519
|
||||||
|
52 Weeks
Ended
January 31,
2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||||||||||||||
|
Tax at federal statutory rate
|
$
|
(9,557
|
)
|
21.0
|
%
|
$
|
(4,791
|
)
|
21.0
|
%
|
$
|
(5,719
|
)
|
21.0
|
%
|
|||||||||
|
State income taxes, net of federal benefit (1)
|
(323
|
)
|
0.7
|
%
|
(133
|
)
|
0.6
|
%
|
(293
|
)
|
1.1
|
%
|
||||||||||||
|
Tax credits
|
(61
|
)
|
0.1
|
%
|
(87
|
)
|
0.4
|
%
|
(107
|
)
|
0.4
|
%
|
||||||||||||
|
Executive compensation
|
—
|
0.0
|
%
|
—
|
0.0
|
%
|
(23
|
)
|
0.1
|
%
|
||||||||||||||
|
Stock based compensation programs
|
159
|
-0.3
|
%
|
111
|
-0.5
|
%
|
209
|
-0.8
|
%
|
|||||||||||||||
|
Changes in valuation allowances
|
10,130
|
-22.3
|
%
|
5,205
|
-22.8
|
%
|
6,399
|
-23.5
|
%
|
|||||||||||||||
|
Other
|
10
|
0.0
|
%
|
11
|
-0.1
|
%
|
53
|
-0.2
|
%
|
|||||||||||||||
|
Income tax expense
|
$
|
358
|
-0.8
|
%
|
$
|
316
|
-1.4
|
%
|
$
|
519
|
-1.9
|
%
|
||||||||||||
|
(1)
|
State taxes in California and Illinois for tax years January 31, 2026 and February 1, 2025 and Tennessee for tax year ended February 3, 2024 made up the
majority (greater than 50%) of the tax effect in this category.
|
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024 |
||||||||||
|
Federal
|
$
|
—
|
$
|
(57
|
)
|
$
|
(73
|
)
|
||||
|
State
|
350
|
392
|
634
|
|||||||||
|
Total
|
$
|
350
|
$
|
335
|
$
|
561
|
||||||
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||
|
Texas
|
$
|
117
|
$
|
123
|
$
|
143
|
||||||
|
Tennessee
|
69
|
35
|
75
|
|||||||||
|
Florida
|
23
|
36
|
37
|
|||||||||
|
Pennsylvania
|
21
|
30
|
59
|
|||||||||
|
Georgia
|
20
|
30
|
58
|
|||||||||
|
Alabama
|
18
|
21
|
•
|
|||||||||
|
Indiana
|
•
|
16
|
29
|
|||||||||
|
Virginia
|
•
|
16
|
•
|
|||||||||
|
South Carolina
|
•
|
15
|
•
|
|||||||||
|
Louisiana
|
•
|
•
|
28
|
|||||||||
|
•
|
Jurisdiction below the threshold for the period presented.
|
|
January 31,
2026
|
February 1,
2025
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Operating lease liabilities
|
$
|
27,878
|
$
|
33,865
|
||||
|
Accruals
|
1,417
|
1,741
|
||||||
|
Inventory valuation
|
236
|
343
|
||||||
|
Federal and state tax credit carryforwards
|
223
|
206
|
||||||
|
Federal and state net operating loss carryforwards
|
27,650
|
18,433
|
||||||
|
Other
|
6,342
|
5,770
|
||||||
|
Total deferred tax assets
|
63,746
|
60,358
|
||||||
|
Valuation allowance for deferred tax assets
|
(36,394
|
)
|
(26,302
|
)
|
||||
|
Net deferred tax assets
|
27,352
|
34,056
|
||||||
|
Deferred tax liabilities:
|
||||||||
|
Property and equipment
|
(1,280
|
)
|
(2,939
|
)
|
||||
|
Operating lease right-of-use assets
|
(25,632
|
)
|
(30,574
|
)
|
||||
|
Prepaid assets
|
(440
|
)
|
(543
|
)
|
||||
|
Total deferred tax liabilities
|
(27,352
|
)
|
(34,056
|
)
|
||||
|
Net deferred tax assets
|
$
|
—
|
$
|
—
|
||||
|
January 31, 2026
|
February 1, 2025
|
||||||||||||||||
|
Fair Value
Hierarchy
|
Carrying Value (1)
|
Fair Value
|
Carrying Value
|
Fair Value
|
|||||||||||||
|
Non-Convertible Term Loan (2)
|
Level 2
|
$
|
—
|
$
|
—
|
$
|
5,531
|
$
|
7,980
|
||||||||
|
Convertible Term Loan (2)
|
Level 2
|
—
|
—
|
6,676
|
7,003
|
||||||||||||
|
Beyond Term Loan (2)
|
Level 2
|
31,185
|
28,612
|
—
|
—
|
||||||||||||
|
Collaboration Agreement fees (3)
|
Level 3
|
6,620
|
5,639
|
3,995
|
5,439
|
||||||||||||
|
(1)
|
See “Note 5 — Long-Term Debt” for further discussion of the carrying values, which is shown on a net basis herein of unamortized debt discount and issuance
costs.
|
|
(2)
|
The fair value was estimated using available market information for debt instruments with similar maturities and credit risk.
|
|
(3)
|
The fair value estimate uses the Company’s estimated future revenue projections over the term of the Collaboration Agreement discounted using current
market rates for debt investments with similar maturities and credit risk.
|
|
January 31, 2026
|
||||
|
Beyond Term Loan
|
$
|
33,732
|
||
|
Collaboration Agreement fees
|
6,620
|
|||
|
Total outstanding related party borrowings
|
40,352
|
|||
|
Less: unamortized debt discount and issuance costs
|
(2,547
|
)
|
||
|
Total related party debt
|
37,805
|
|||
|
Less: current portion of related party debt
|
(1,361
|
)
|
||
|
Related party debt, net
|
$
|
36,444
|
||
|
January 31, 2026
|
February 1, 2025
|
|||||||
|
Revolving line of credit
|
$
|
15,986
|
$
|
43,000
|
||||
|
Non-Convertible Term Loan
|
—
|
8,500
|
||||||
|
Convertible Term Loan
|
—
|
8,500
|
||||||
|
Collaboration Agreement fees
|
—
|
3,995
|
||||||
|
Total outstanding borrowings
|
15,986
|
63,995
|
||||||
|
Less: unamortized debt discount and issuance costs
|
—
|
(4,793
|
)
|
|||||
|
Total debt
|
15,986
|
59,202
|
||||||
|
Less: current portion of long-term debt
|
—
|
(49,199
|
)
|
|||||
|
Long-term debt, net
|
$
|
15,986
|
$
|
10,003
|
||||
|
Scheduled
Maturities
|
||||
|
2026
|
$
|
1,471
|
||
|
2027
|
1,378
|
|||
|
2028
|
1,378
|
|||
|
2029
|
51,096
|
|||
|
2030
|
1,378
|
|||
|
Thereafter
|
1,378
|
|||
|
Total scheduled maturities
|
58,079
|
|||
|
Less: unamortized debt discount and issuance costs
|
(2,547
|
)
|
||
|
Less: present value of collaboration agreement fees
|
(3,267
|
)
|
||
|
Total debt
|
$
|
52,265
|
||
|
52 Week Period
Ended (1)
|
52 Week Period
Ended (1)
|
53 Week Period
Ended (1)
|
||||||||||
|
January 31, 2026
|
February 1, 2025
|
February 3, 2024
|
||||||||||
|
Cost of sales (2)
|
||||||||||||
|
Operating lease cost
|
$
|
44,955
|
$
|
45,373
|
$
|
46,066
|
||||||
|
Short-term lease cost
|
783
|
743
|
1,308
|
|||||||||
|
Variable lease cost
|
641
|
1,067
|
1,226
|
|||||||||
|
Total lease cost in cost of sales
|
46,379
|
47,183
|
48,600
|
|||||||||
|
Other operating expenses
|
||||||||||||
|
Operating lease cost
|
1,197
|
1,201
|
1,651
|
|||||||||
|
Short-term lease cost
|
57
|
63
|
66
|
|||||||||
|
Total lease cost in other operating expenses
|
1,254
|
1,264
|
1,717
|
|||||||||
|
Total lease cost
|
$
|
47,633
|
$
|
48,447
|
$
|
50,317
|
||||||
|
(1)
|
Total lease cost excludes expense for non-lease components including common area maintenance and excludes costs that are not a component of the lease
including insurance, taxes and utilities for the Company’s leases.
|
|
(2)
|
Cost of sales includes all distribution center lease costs and store occupancy-related lease costs.
|
|
Operating
Leases |
||||
|
2026
|
$
|
42,717
|
||
|
2027
|
34,820
|
|||
|
2028
|
24,829
|
|||
|
2029
|
16,327
|
|||
|
2030
|
8,898
|
|||
|
Thereafter
|
8,344
|
|||
|
Total lease payments
|
135,935
|
|||
|
Less: interest
|
(23,929
|
)
|
||
|
Present value of lease liabilities
|
$
|
112,006
|
||
|
January 31,
2026
|
||||
|
Weighted-average remaining lease term (years)
|
4.2
|
|||
|
Weighted-average discount rate
|
9.8
|
%
|
||
|
52 Weeks Ended
January 31, 2026
|
52 Weeks Ended
February 1, 2025
|
53 Weeks Ended
February 3, 2024
|
||||||||||
|
Operating cash flows from operating leases
|
$
|
45,381
|
$
|
46,122
|
$
|
55,805
|
||||||
|
Shares
|
Weighted
Average Grant Date
Fair Value
|
|||||||
|
Non-Vested at January 31, 2026
|
517,151
|
$
|
2.77
|
|||||
|
Granted
|
1,983,772
|
1.52
|
||||||
|
Vested
|
(141,006
|
)
|
3.36
|
|||||
|
Forfeited
|
(595,660
|
)
|
1.72
|
|||||
|
Non-Vested at February 1, 2025
|
1,764,257
|
$
|
1.67
|
|||||
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||
|
Weighted average grant date fair value of RSUs (per share)
|
$
|
1.52
|
$
|
2.29
|
$
|
2.83
|
||||||
|
Total fair value of restricted stock units vested (in thousands)
|
$
|
183
|
$
|
455
|
$
|
560
|
||||||
|
Number of
Options
|
Weighted
Average
Exercise
Price
|
Weighted Average
Remaining
Contractual
Term (in years)
|
Aggregate
Intrinsic
Value (in
thousands)
|
|||||||||||||
|
Balance at February 1, 2025
|
441,309
|
$
|
4.45
|
|||||||||||||
|
Options granted
|
—
|
|||||||||||||||
|
Options forfeited
|
(68,086
|
)
|
3.32
|
|||||||||||||
|
Options expired
|
(148,676
|
)
|
5.63
|
|||||||||||||
|
Balance at January 31, 2026
|
224,547
|
$
|
4.00
|
7.5
|
$
|
—
|
||||||||||
|
Options Exercisable As of:
|
||||||||||||||||
|
January 31, 2026
|
88,000
|
$
|
4.33
|
6.8
|
$
|
—
|
||||||||||
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||
|
Weighted average grant date fair value of options granted (per share)
|
$
|
—
|
$
|
1.82
|
$
|
2.06
|
||||||
|
Total fair value of stock options vested (in thousands)
|
$
|
211
|
$
|
235
|
$
|
57
|
||||||
|
Intrinsic value of stock options exercised (in thousands)
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
|||||||
|
Expected price volatility
|
93.5
|
%
|
92.4
|
%
|
||||
|
Risk-free interest rate
|
4.1
|
%
|
3.3
|
%
|
||||
|
Expected life (in years)
|
6
|
6
|
||||||
|
Dividend yield
|
0
|
%
|
0
|
%
|
||||
|
52 Weeks
Ended January
31, 2026 |
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||
|
Impairment of leasehold improvements, fixtures and equipment at stores
|
$
|
1,739
|
$
|
109
|
$
|
648
|
||||||
|
Impairment of right-of-use assets
|
274
|
—
|
—
|
|||||||||
|
Impairment of software projects
|
—
|
—
|
676
|
|||||||||
|
Impairment of software as a service implementation costs
|
—
|
—
|
324
|
|||||||||
|
Impairment of e-commerce distribution center fixtures
|
—
|
—
|
95
|
|||||||||
|
Impairment of other long-lived assets
|
—
|
—
|
124
|
|||||||||
|
Total impairment
|
$
|
2,013
|
$
|
109
|
$
|
1,867
|
||||||
|
Number of stores with leasehold improvements, fixtures and equipment impairment
|
28
|
4
|
7
|
|||||||||
33
| • |
At the effective time of the Merger (the ‘‘Effective Time’’), each share of common stock, no par value, of TBHC (the ‘‘TBHC Common Stock’’) issued and
outstanding immediately prior to the Effective Time (other than treasury shares and any shares of TBHC Common Stock held directly by BBBY or Merger Sub) will be converted into the right to receive 0.1993 (the ‘‘Exchange Ratio’’) of a fully
paid and non-assessable share of common stock, par value $0.0001 per share, of BBBY (the ‘‘BBBY Common Stock’’) and, if applicable, cash in lieu of fractional shares of BBBY Common Stock, subject to any applicable withholding.
|
| • |
At the Effective Time, (i) each award of TBHC restricted share units (‘‘TBHC RSU’’) that is outstanding as of immediately prior to the Effective Time
will automatically fully vest and be converted into the right to receive, without interest and subject to applicable withholding taxes, a number of validly issued, fully paid and nonassessable shares of BBBY Common Stock equal to (A) the
number of shares of TBHC Common Stock subject to the TBHC RSU multiplied by (B) the Exchange Ratio, plus, if applicable, cash in lieu of fractional shares, and (ii)
each option to purchase TBHC Common Stock (‘‘TBHC Option’’) that is outstanding as of immediately prior to the Effective Time will be automatically cancelled and converted into the right to receive, without interest and subject to
applicable withholding taxes, a number of validly issued, fully paid and nonassessable shares of BBBY Common Stock equal to (A) the Net Option Share Amount (as defined in the Merger Agreement) applicable to the TBHC Option multiplied by (B)
the Exchange Ratio, plus, if applicable, cash in lieu of fractional shares.
|
| • |
The historical audited consolidated financial statements of BBBY as of and for the fiscal year ended December 31, 2025, as included in BBBY’s Annual
Report on Form 10-K filed with the SEC on February 24, 2026 ; and
|
| • |
The historical audited consolidated financial statements of TBHC as of and for the fiscal year ended January 31, 2026, as included herein as Exhibit
99.1 to the Current Report on Form 8-K/A of which this Exhibit 99.2 forms a part;
|
| • |
Certain reclassifications to conform TBHC’s historical financial statement presentation to BBBY’s historical financial statement presentation;
|
| • |
Adjustments to reflect purchase accounting under Accounting Standards Codification 805, Business Combinations (‘‘ASC 805’’); and
|
| • |
Non-recurring transaction costs in connection with the Merger.
|
|
|
As of December
31, 2025
|
As of January 31,
2026
|
As of December 31, 2025
|
||||||||||||||||
|
|
Bed Bath & Beyond,
Inc. (Historical)
|
The Brand House
Collective, Inc.
(Historical, adjusted for
reclassifications)
|
Transaction
Adjustments
|
(Note 3)
|
Pro Forma
Combined
|
||||||||||||||
|
Assets
|
|||||||||||||||||||
|
Current assets:
|
|||||||||||||||||||
|
Cash and cash equivalents
|
$
|
175,295
|
$
|
2,932
|
$
|
(5,037
|
)
|
A
|
$
|
173,190
|
|||||||||
|
Restricted cash
|
26,924
|
-
|
-
|
26,924
|
|||||||||||||||
|
Accounts receivable, net of allowance for credit losses
|
20,829
|
-
|
(3,713
|
)
|
B
|
17,116
|
|||||||||||||
|
Inventories
|
5,162
|
58,758
|
6,674
|
B
|
70,594
|
||||||||||||||
|
Prepaid expenses and other current assets
|
11,905
|
7,049
|
-
|
18,954
|
|||||||||||||||
|
Total current assets
|
240,115
|
68,739
|
(2,076
|
)
|
306,778
|
||||||||||||||
|
Property and equipment, net
|
13,712
|
14,710
|
-
|
28,422
|
|||||||||||||||
|
Intangible assets, net
|
45,140
|
-
|
-
|
45,140
|
|||||||||||||||
|
Goodwill
|
6,160
|
-
|
53,015
|
B
|
59,175
|
||||||||||||||
|
Equity securities, including securities measured at fair value
|
66,641
|
-
|
(1,430
|
)
|
C
|
56,813
|
|||||||||||||
|
|
(8,398
|
)
|
B
|
||||||||||||||||
|
Operating lease right-of-use assets
|
5,156
|
102,280
|
15,526
|
D
|
122,962
|
||||||||||||||
|
Other long-term assets, net including securities measured at fair value
|
48,554
|
2,604
|
(31,185
|
)
|
B
|
19,973
|
|||||||||||||
|
Total assets
|
$
|
425,478
|
$
|
188,333
|
$
|
25,452
|
$
|
639,263
|
|||||||||||
|
Liabilities and Stockholders' Equity (Deficit)
|
|||||||||||||||||||
|
Current liabilities:
|
|||||||||||||||||||
|
Accounts payable
|
$
|
89,992
|
$
|
55,348
|
$
|
(537
|
)
|
A
|
$
|
141,090
|
|||||||||
|
|
(3,713
|
)
|
B
|
||||||||||||||||
|
Accrued liabilities
|
51,297
|
17,584
|
(983
|
)
|
A
|
67,898
|
|||||||||||||
|
Unearned revenue
|
34,429
|
309
|
-
|
34,738
|
|||||||||||||||
|
Operating lease liabilities, current
|
928
|
33,821
|
-
|
34,749
|
|||||||||||||||
|
Short-term debt, net
|
15,500
|
-
|
-
|
15,500
|
|||||||||||||||
|
Current related party debt, net
|
-
|
1,361
|
(1,361
|
)
|
B
|
-
|
|||||||||||||
|
Total current liabilities
|
192,146
|
108,423
|
(6,594
|
)
|
293,975
|
||||||||||||||
|
Long-term debt, net
|
-
|
15,986
|
(10,000
|
)
|
B
|
5,986
|
|||||||||||||
|
Operating lease liabilities, non-current
|
5,643
|
78,185
|
5,800
|
E
|
89,628
|
||||||||||||||
|
Other long-term liabilities, including commitments measured at fair value
|
9,745
|
3,172
|
(2,766
|
)
|
F
|
10,151
|
|||||||||||||
|
Related party debt, net
|
-
|
36,444
|
(36,444
|
)
|
B
|
-
|
|||||||||||||
|
Total liabilities
|
207,534
|
242,210
|
(50,004
|
)
|
399,740
|
||||||||||||||
|
Stockholders’ equity (deficit):
|
|||||||||||||||||||
|
Preferred stock
|
-
|
-
|
|||||||||||||||||
|
Common stock
|
8
|
188,549
|
(188,549
|
)
|
B
|
8
|
|||||||||||||
|
Additional paid‑in capital
|
1,239,338
|
-
|
23,760
|
B
|
1,263,098
|
||||||||||||||
|
Accumulated deficit
|
(842,711
|
)
|
(242,426
|
)
|
242,426
|
B
|
(844,892
|
)
|
|||||||||||
|
|
(3,517
|
)
|
A
|
||||||||||||||||
|
|
(1,430
|
)
|
C
|
||||||||||||||||
|
|
2,766
|
F
|
|||||||||||||||||
|
Accumulated other comprehensive loss
|
(2,574
|
)
|
-
|
- |
(2,574
|
)
|
|||||||||||||
|
Treasury stock at cost
|
(176,478
|
)
|
-
|
-
|
(176,478
|
)
|
|||||||||||||
|
Total stockholders’ equity (deficit) attributable to stockholders of Bed Bath & Beyond, Inc.
|
217,583
|
(53,877
|
)
|
75,456
|
239,162
|
||||||||||||||
|
Equity attributable to noncontrolling interests
|
361
|
-
|
-
|
361
|
|||||||||||||||
|
Total stockholders’ equity (deficit)
|
217,944
|
(53,877
|
)
|
75,456
|
239,523
|
||||||||||||||
|
Total liabilities and stockholders’ equity (deficit)
|
$
|
425,478
|
$
|
188,333
|
$
|
25,452
|
$
|
639,263
|
|||||||||||
|
Year Ended
December 31, 2025
|
Year Ended January 31, 2026
|
The Year Ended December 31, 2025
|
|||||||||||||||
|
Bed Bath & Beyond, Inc.
(Historical)
|
The Brand House Collective,
Inc. (Historical, adjusted for
reclassifications)
|
Transaction
Adjustments
|
(Note 4)
|
Pro Forma Combined
|
|||||||||||||
|
Net revenue
|
$
|
1,044,616
|
$
|
395,782
|
$
|
(2,417
|
)
|
AA
|
$
|
1,437,981
|
|||||||
|
Cost of goods sold
|
787,094
|
310,709
|
(1,651
|
)
|
AA
|
1,102,826
|
|||||||||||
|
|
6,674
|
BB
|
|||||||||||||||
|
Gross profit
|
257,522
|
85,073
|
(7,440
|
)
|
335,155
|
||||||||||||
|
Operating expenses:
|
|||||||||||||||||
|
Sales and marketing
|
143,356
|
2,027
|
-
|
145,383
|
|||||||||||||
|
Technology
|
90,276
|
9,620
|
-
|
99,896
|
|||||||||||||
|
General and administrative
|
53,569
|
121,127
|
3,517
|
CC
|
178,213
|
||||||||||||
|
Customer service and merchant fees
|
37,324
|
-
|
-
|
37,324
|
|||||||||||||
|
Other operating expense (income), net
|
(5,790
|
)
|
-
|
-
|
(5,790
|
)
|
|||||||||||
|
Gain on sale of internally developed intangible assets
|
-
|
(10,000
|
)
|
10,000
|
DD
|
-
|
|||||||||||
|
Asset impairment
|
-
|
2,013
|
-
|
2,013
|
|||||||||||||
|
Total operating expenses
|
318,735
|
124,787
|
13,517
|
457,039
|
|||||||||||||
|
Operating loss
|
(61,213
|
)
|
(39,714
|
)
|
(20,957
|
)
|
(121,884
|
)
|
|||||||||
|
Interest income, net
|
5,052
|
(6,024
|
)
|
1,588
|
EE
|
616
|
|||||||||||
|
Other (expense) income, net
|
(27,635
|
)
|
230
|
5,815
|
FF
|
(21,590
|
)
|
||||||||||
|
Loss before income taxes
|
(83,796
|
)
|
(45,508
|
)
|
(13,554
|
)
|
(142,858
|
)
|
|||||||||
|
Provision for income taxes
|
825
|
358
|
-
|
1,183
|
|||||||||||||
|
Consolidated net loss
|
(84,621
|
)
|
(45,866
|
)
|
(13,554
|
)
|
(144,041
|
)
|
|||||||||
|
Less: Net loss attributable to noncontrolling interests
|
-
|
-
|
-
|
-
|
|||||||||||||
|
Net loss attributable to stockholders of Bed Bath & Beyond, Inc.
|
$
|
(84,621
|
)
|
$
|
(45,866
|
)
|
$
|
(13,554
|
)
|
$
|
(144,041
|
)
|
|||||
|
|
|||||||||||||||||
|
Net loss per share, basic and diluted
|
$
|
(1.41
|
)
|
$
|
(2.05
|
)
|
$
|
(2.28
|
)
|
||||||||
|
Weighted average common shares outstanding, basic and diluted
|
60,130
|
22,369
|
(19,416
|
)
|
GG
|
63,083
|
|||||||||||
|
Bed Bath & Beyond, Inc.
|
The Brand House Collective, Inc.
|
The Brand
House
Collective, Inc.
|
Reclassification Adjustments
|
Notes
|
The Brand House
Collective, Inc.
(Historical,
adjusted for
reclassifications)
|
||||||||||
|
Assets
|
|
|
|||||||||||||
|
Current assets:
|
|
|
|||||||||||||
|
Cash and cash equivalents
|
Cash and cash equivalents
|
$
|
2,932
|
$
|
-
|
|
$
|
2,932
|
|||||||
|
Restricted cash
|
|
-
|
-
|
|
-
|
||||||||||
|
Accounts receivable, net of allowance for credit losses
|
|
-
|
-
|
|
-
|
||||||||||
|
Inventories
|
Inventories, net
|
58,758
|
-
|
|
58,758
|
||||||||||
|
Prepaid expenses and other current assets
|
Prepaid expenses and other current assets
|
7,049
|
-
|
|
7,049
|
||||||||||
|
Total current assets
|
|
68,739
|
-
|
|
68,739
|
||||||||||
|
Property and equipment, net
|
Property and equipment, net
|
14,710
|
-
|
|
14,710
|
||||||||||
|
Intangible assets, net
|
|
-
|
-
|
|
-
|
||||||||||
|
Goodwill
|
|
-
|
-
|
|
-
|
||||||||||
|
Equity securities, including securities measured at fair value
|
|
-
|
-
|
|
-
|
||||||||||
|
Operating lease right-of-use assets
|
Operating lease right-of-use assets
|
102,280
|
-
|
|
102,280
|
||||||||||
|
Other long-term assets, net including securities measured at fair value
|
Other assets
|
2,604
|
-
|
|
2,604
|
||||||||||
|
Total assets
|
|
$
|
188,333
|
$
|
-
|
|
$
|
188,333
|
|||||||
|
Liabilities and Stockholder's Equity (Deficit)
|
|
|
|||||||||||||
|
Current liabilities:
|
|
|
|||||||||||||
|
Accounts payable
|
Accounts payable
|
$
|
55,348
|
$
|
-
|
|
$
|
55,348
|
|||||||
|
Accrued liabilities
|
Accrued expenses and other liabilities
|
17,893
|
(309
|
)
|
(a)
|
17,584
|
|||||||||
|
Unearned revenue
|
|
-
|
309
|
(a)
|
309
|
||||||||||
|
Operating lease liabilities, current
|
Operating lease liabilities
|
33,821
|
-
|
|
33,821
|
||||||||||
|
Short-term debt, net
|
|
-
|
-
|
|
-
|
||||||||||
|
Current related party debt, net
|
|
1,361
|
-
|
1,361
|
|||||||||||
|
Total current liabilities
|
|
108,423
|
-
|
|
108,423
|
||||||||||
|
Long-term debt, net
|
|
15,986
|
-
|
15,986
|
|||||||||||
|
Operating lease liabilities, non-current
|
Operating lease liabilities
|
78,185
|
-
|
|
78,185
|
||||||||||
|
Other long-term liabilities, including commitments measured at fair value
|
Other liabilities
|
3,172
|
-
|
|
3,172
|
||||||||||
|
Related party debt, net
|
|
36,444
|
-
|
36,444
|
|||||||||||
|
Total liabilities
|
|
242,210
|
-
|
|
242,210
|
||||||||||
|
Stockholders’ equity (deficit):
|
|
|
|||||||||||||
|
Preferred stock
|
Preferred stock
|
-
|
-
|
|
-
|
||||||||||
|
Common stock
|
Common stock
|
188,549
|
-
|
|
188,549
|
||||||||||
|
Additional paid‑in capital
|
Additional paid‑in capital
|
-
|
-
|
|
-
|
||||||||||
|
Accumulated deficit
|
|
(242,426
|
)
|
-
|
|
(242,426
|
)
|
||||||||
|
Treasury stock at cost
|
|
-
|
-
|
|
-
|
||||||||||
|
Total stockholders’ equity (deficit) attributable to stockholders of Bed Bath & Beyond, Inc.
|
|
(53,877
|
)
|
-
|
|
(53,877
|
)
|
||||||||
|
Equity attributable to noncontrolling interests
|
|
-
|
-
|
|
-
|
||||||||||
|
Total stockholders’ equity (deficit)
|
|
(53,877
|
)
|
-
|
|
(53,877
|
)
|
||||||||
|
Total liabilities and stockholders’ equity (deficit)
|
|
$
|
188,333
|
$
|
-
|
|
$
|
188,333
|
|||||||
| (a) |
Reclassification of TBHC’s unearned revenue to conform to BBBY’s historical presentation
|
|
Bed Bath & Beyond, Inc.
|
The Brand House Collective, Inc.
|
The Brand
House
Collective, Inc. |
Reclassification Adjustments
|
Notes
|
The Brand
House
Collective, Inc.
(Historical,
adjusted for
reclassifications)
|
||||||||||
|
Net revenue
|
Net sales
|
$
|
395,782
|
$
|
-
|
|
$
|
395,782
|
|||||||
|
Cost of goods sold
|
Cost of sales
|
310,709
|
-
|
|
310,709
|
||||||||||
|
Gross profit
|
Gross profit
|
85,073
|
-
|
|
85,073
|
||||||||||
|
Operating expenses:
|
Operating expenses:
|
|
|||||||||||||
|
Sales and marketing
|
|
-
|
1,549
|
(b)
|
2,027
|
||||||||||
|
|
|
478
|
(c)
|
||||||||||||
|
Technology
|
|
-
|
2,926
|
(b)
|
9,620
|
||||||||||
|
|
|
4,828
|
(c)
|
||||||||||||
|
|
|
1,866
|
(d)
|
||||||||||||
|
General and administrative
|
|
-
|
72,341
|
(b)
|
121,127
|
||||||||||
|
|
|
48,333
|
(c)
|
||||||||||||
|
|
|
453
|
(d)
|
||||||||||||
|
Customer service and merchant fees
|
|
-
|
-
|
|
-
|
||||||||||
|
Compensation and benefits
|
76,816
|
(76,816
|
) |
(b)
|
-
|
||||||||||
|
Other operating expenses (income), net
|
Other operating expenses
|
53,639
|
(53,639
|
)
|
(c)
|
-
|
|||||||||
|
Depreciation (exclusive of depreciation included in cost of sales)
|
2,319
|
(2,319
|
) |
(d)
|
-
|
||||||||||
|
Gain on sale of internally developed intangible assets
|
(10,000
|
) |
-
|
|
(10,000
|
) |
|||||||||
|
Asset impairment
|
2,013
|
-
|
|
2,013
|
|||||||||||
|
Total operating expenses
|
Total operating expenses
|
124,787
|
-
|
|
124,787
|
||||||||||
|
Operating loss
|
Operating loss
|
(39,714
|
)
|
-
|
|
(39,714
|
) |
||||||||
|
Interest income, net
|
|
-
|
(6,024
|
)
|
(e)
|
(6,024
|
) |
||||||||
|
Interest expense
|
(6,024
|
) |
6,024
|
(e)
|
-
|
||||||||||
|
Other income (expense), net
|
Other income
|
230
|
-
|
|
230
|
||||||||||
|
Loss before income taxes
|
Loss before income taxes
|
(45,508
|
)
|
-
|
|
(45,508
|
) |
||||||||
|
Provision for income taxes
|
Income tax expense (benefit)
|
358
|
-
|
|
358
|
||||||||||
|
Consolidated net loss
|
Net loss
|
$
|
(45,866
|
)
|
$
|
-
|
|
$
|
(45,866
|
) |
|||||
| (b) |
Reclassification of ‘‘Compensation and benefits’’ to ‘‘Sales and marketing,’’ ‘‘Technology,’’ ‘‘General and administrative,’’ and ‘‘Customer service and merchant fees.’’
|
| (c) |
Reclassification of ‘‘Other operating expenses’’ to ‘‘Sales and marketing,’’ ‘‘Technology,’’ and ‘‘General and administrative.’’
|
| (d) |
Reclassification of ‘‘Depreciation (exclusive of depreciation included in cost of sales)’’ to ‘‘Technology’’ and ‘‘General and administrative.’’
|
| (e) |
Reclassification of ‘‘Interest expense’’ to ‘‘Interest income, net.’’
|
| A. |
Reflects the impact of $5.0 million of nonrecurring expenses related to estimated transaction
costs of TBHC primarily comprised of investment banking fees, legal fees and other related advisory costs, and directors’ and officers’ liability tail insurance. The related adjustment to the statement of operations is reflected at
adjustment CC, as described in further detail in ‘‘—Note 4 —Adjustments to the Unaudited Pro Forma Combined Statement of
Operations for Year Ended December 31, 2025” below.
|
| B. |
Reflects the preliminary purchase consideration
allocation adjustments to record TBHC’s assets and liabilities at estimated fair value based on the consideration conveyed. The subsequent impacts to the statement of operations resulting from the acquisition are discussed in the
subsequent notes below. The preliminary purchase consideration was allocated among the identified net assets to be acquired, based on a preliminary analysis. Goodwill is expected to be recognized as a result of the Merger, which
represents the excess fair value of consideration over the fair value of the underlying net assets of TBHC. This was considered appropriate based on the determination that the Merger would be accounted for as a business combination under
ASC 805. The estimates of fair value are based upon preliminary valuation assumptions, and are believed to be reasonable, but are inherently uncertain. As a result,
actual results may differ from estimates, and the difference may be material.
|
|
Cash and cash equivalents
|
$
|
2,932
|
||
|
Inventories (1)
|
65,432
|
|||
|
Prepaid expenses and other current assets
|
7,049
|
|||
|
Property and equipment
|
14,710
|
|||
|
Operating lease right-of-use assets
|
117,806
|
|||
|
Other long-term assets
|
2,604
|
|||
|
Total assets
|
$
|
210,533
|
||
|
Accounts payable
|
51,635
|
|||
|
Accrued liabilities
|
17,584
|
|||
|
Unearned revenue
|
309
|
|||
|
Operating lease liabilities, current
|
33,821
|
|||
|
Long-term debt
|
5,986
|
|||
|
Operating lease liabilities, non-current
|
83,985
|
|||
|
Other liabilities
|
3,172
|
|||
|
Net assets acquired
|
14,041
|
|||
|
Goodwill
|
53,015
|
|||
|
Fair value of consideration transferred (2)
|
$
|
67,056
|
| (1) |
A step up in inventories of $6.7 million was made to adjust the inventories to their estimated fair value. The Inventories fair value of $65.4 million
was estimated using the comparative sales method approach. The related adjustment to the statement of operations for inventories is reflected at adjustment BB, as described in further detail in ‘‘—Note 4 — Adjustments to the Unaudited Pro Forma Condensed Combined Statement of Operations for the Year Ended December 31, 2025’’ below.
|
| (2) |
The preliminary purchase consideration to be transferred for TBHC is approximately $67.1 million based on following: 1) TBHC shareholders receiving 2.7
million shares of BBBY Common Stock at a closing share price of $4.66 as of April 1, 2026, 2) a total of $1.2 million attributable to the fair value of BBBY Common Stock issued to TBHC in exchange for RSUs that accelerated due to the change
in control provision, 3) existing equity interests in TBHC of $8.4 million, 4) settlement of indebtedness of $10.0 million and 5) settlement of preexisting relationships of $34.9 million.
|
|
(in thousands, except exchange ratio)
|
As of April 1, 2026
|
|||
|
TBHC's shares outstanding as of April 1, 2026
|
22,508
|
|||
|
Existing shares in TBHC held by BBBY
|
(8,934
|
)
|
||
|
TBHC's shares outstanding as of April 1, 2026, excluding shares owned by BBBY
|
13,574
|
|||
|
Exchange ratio as per the merger agreement
|
0.1993
|
|||
|
Total estimated outstanding shares
|
2,705
|
|||
|
BBBY's stock price as of April 1, 2026
|
$
|
4.66
|
||
|
Share consideration
|
$
|
12,605
|
||
|
Add: Accelerated vesting of equity awards
|
1,155
|
|||
|
Add: Fair value of existing equity interest held by BBBY
|
8,398
|
|||
|
Add: Settlement of indebtedness
|
10,000
|
|||
|
Add: Settlement of preexisting relationships (1)
|
34,898
|
|||
|
Fair value of consideration transferred
|
$
|
67,056
|
||
| (1) |
Represents the settlement of preexisting relationships between BBBY and TBHC at the time of the Merger execution including $31.2 million in related
party debt between BBBY and TBHC and $3.7 million of accounts receivable from inventory sales to TBHC.
|
|
|
Common Stock
|
Additional Paid-in
Capital
|
Accumulated Deficit
|
|||||||||
|
Elimination of historical TBHC equity
|
$
|
(188,549
|
)
|
$
|
-
|
$
|
242,426
|
|||||
|
Settlement of indebtedness
|
-
|
10,000
|
-
|
|||||||||
|
Issuance of the Company's common stock and accelerated vesting of RSUs
|
-
|
13,760
|
-
|
|||||||||
|
Total unaudited pro forma adjustments to equity
|
$
|
(188,549
|
)
|
$
|
23,760
|
$
|
242,426
|
|||||
| C. |
Reflects the final fair value adjustment of BBBY’s equity method investment in TBHC. BBBY used TBHC’s ending stock price on April 1, 2026, for purposes
of determining the final fair value adjustment of $1.4 million.
|
| D. |
Reflects a $15.5 million adjustment to remeasure TBHC’s operating lease right-of-use assets so that the operating lease right-of use assets equal
the corresponding lease liabilities at the acquisition date in accordance with ASC 842-10-55-11 and ASC 805-20-30-24.
|
| E. |
Reflects a $5.8 million adjustment to TBHC’s operating lease liabilities to remeasure the liabilities at the acquisition date using BBBY’s incremental
borrowing rate, as required for an acquirer’s measurement of acquired lease liabilities.
|
| F. |
BBBY elected the fair value option for its investment in TBHC and thus, all other financial interests eligible for the fair value election (including
the delayed draw commitment) were required to be subsequently measured at fair value. As a result, the delayed draw commitment is accounted for as a financial instrument measured at fair value. The adjustment is eliminating the recognition
of the impact of measuring the financial instrument at fair value as there would be no fair value adjustment from an intercompany lending perspective.
|
| AA. |
Reflects the elimination of $0.8 million in collaboration fee revenue recognized by BBBY from their collaboration agreement with TBHC. In addition, this
adjustment reflects the elimination of $1.7 million in net revenue and cost of goods sold, related to inventory sold by BBBY to TBHC as this would be considered intercompany and eliminated in consolidation.
|
| BB. |
Reflects the amortization of the inventory fair value adjustment. For purposes of the unaudited pro forma condensed combined financial information, the inventories step-up
amortization period was determined to be 3 months which approximates BBBY’s historical inventory turnover.
|
| CC. |
Reflects the recognition of $3.5 million of nonrecurring expense incurred in connection with the Merger that were not reflected in the historical statements of operations.
These transaction costs are primarily comprised of investment banking fees, legal fees and other related advisory costs, and directors’ and officers’ liability tail
insurance.
|
| DD. |
Reflects the elimination of TBHC’s gain on sale of internally developed intangible assets sold to BBBY as this would be considered intercompany and eliminated in consolidation.
|
| EE. |
For the year ended December 31, 2025, this adjustment relates to the elimination of intercompany interest expense of $2.5 million (TBHC). In addition, this adjustment reflects
the elimination of BBBY’s interest income of $0.9 million for the year ended December 31, 2025. This interest income was generated from the debt agreement between BBBY (the lender) and TBHC (the borrower) as this would be considered
intercompany and eliminated in consolidation.
|
| FF. |
For the year ended December 31, 2025, this adjustment relates to the derivative impact of $0.6 million (BBBY) resulting from the delayed draw commitment and the $5.2 million
(BBBY) change in fair value of equity method investment.
|
| GG. |
Pro forma basic and diluted weighted average common shares outstanding have been adjusted for the following:
|
|
|
Year Ended
December 31, 2025
|
|||
|
Historical Weighted Average number of the Company's shares outstanding - basic and dilutive
|
60,130
|
|||
|
Impact of issuance of the Company's shares to TBHC shareholders assuming issuance as of January 1, 2025
|
2,705
|
|||
|
Impact of acceleration of RSUs assuming acceleration as of January 1, 2025
|
248
|
|||
|
|
63,083
|
|||
